The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

NCT02103049 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia
Transplants

Interventions

DRUG: Ezetimibe

Sponsor

University Medical Centre Ljubljana